PRODUCTAbcalis® Multiclonals™
A revolutionary new class of secondary antibodies
WHYWhy use Multiclonals™?
Abcalis® believes that the future of secondary antibodies is recombinant, sequence defined and animal free. In therapeutics, recombinant antibodies have long been the gold standard for real-world application and we do not see any reason why this should be different for diagnostics and research.
Multiclonals™ combine the best of polyclonal antisera and hybridoma monoclonal antibodies, while eliminating their disadvantages, plus they add the unlimited availability and sequence defined quality of recombinant reagents.
WHATWhat are Multiclonals™?
Our Multiclonal™ antibodies are a mixture of different, individually characterized and carefully selected recombinant monoclonal immunoglobulins. Their respective epitope binding sites do not compete with each other, providing increased signal strength in your assays.
- Animal-free & sequence defined
- Antibody composition completely known, can even be adapted on customers demand
- Defined epitopes for all antibodies in the mix
- No unknown immunogobulin content
- 100% Batch-to-Batch consistency
- Unlimited reproducibility
ADVANTAGESBest of both Worlds
As is the standard with all Abcalis® products, they are all completely sequence defined, implying their unlimited long-term availability and always identical test results. Their composition from a limited number of individually characterised antibodies minimizes cross-reactivity with other targets, since they do not contain non-target directed IgG like all animal-derived polyclonal sera do. This allows for a much lower unspecific binding reactivity in many assays compared to animal based products.
Need more information?
